THE IMPORTANCE OF SENTINEL LYMPH NODES BIOPSY IN EARLY-STAGE OF BREAST CANCER
Keywords:
Sentinel Lymph Node, Breast Cancer, Axillary lymph node dissection, Neoadjuvant chemotherapy, Node positive, Macrometastasis, MicrometastasisAbstract
Sentinel lymph node biopsy is a safe and reliable procedure for the initial staging of breast cancer. Over the past decade, growing evidence has supported its use, and it is now regarded as the standard of care for evaluating metastatic spread to the axillary lymph nodes. Axillary lymph node involvement is still an important predictor of recurrence and survival in breast cancer. Axillary staging was classically done by axillary lymph node dissection (ALND), but the introduction of sentinel lymph node biopsy (SLNB) has led to a progressive and continuing de-escalation in its use.
References
[1] Atalay C. New concepts in axillary management of breast cancer. World J Clin Oncol. 2014; 5: 895–900.
[2] Benitez A, Cortés M, Bajén M, Gasén AR, Sabaté A. Ganglio centinela, ROLL y SNOLL en cáncer de mama. In: Soriano A, Martin J, Garcia A, (eds). Medicina nuclear en la práctica clínica (pp. 571–584). 2nd ed. Grupo Aula Médica: Madrid; 2012.
[3] Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009; 27: 2946–2953.
[4] Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977; 39: 456–466.
[5] Harlow SP, Weaver DL. Sentinel lymph node in breast cancer: Techniques. 2016. Available at: UpToDate. (Accessed: 1 December 2016).
[6] Kell MR, Burke JP, Barry M, Morrow M. Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat. 2010; 120: 441–447.
[7] Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer. 2006; 106: 4–16.
[8] Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. J Surg Oncol. 1993; 62: 335–340.
[9] Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010; 11: 927–933.
[10] Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23: 7703–7720.
[11] Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2014; 32: 1365–1383.
[12] Magnoni F, Veronesi P. Sentinel node biopsy in conservative surgery for breast cancer: a changing role in clinical practice. Minerva Chir. 2020; 75: 386–391.
[13] Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006; 98: 599–609.
[14] Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg. 2004; 240: 462–471.
[15] Riogi B, Sripadam R, Barker D, Harris O, Innes H, Chagla L. Management of the axilla following neoadjuvant chemotherapy for breast cancer: a change in practice. Surgeon. 2021; 19: 1–7.
[16] Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer. 2002; 94: 2542–2551.
[17] Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003; 349: 546–553.
